血尿酸对膝骨关节炎患者WOMAC指数变化的影响研究

摘要
图/表
参考文献
相关文章 (3)

全文: PDF (484 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的分析血尿酸水平对膝关节骨关节炎患者WOMAC骨关节炎指数的相关性。方法研究入组患者312例，采用多元线性回归分析各因素对WOMAC的影响。结果患者WOMAC评分与尿酸呈负相关，其Pearson相关系数(r)为－0.824 8(P＜0.000 1)。性别、BMI和尿酸水平对于WOMAC具有影响，其多元回归方程为WOMAC＝－7.811+0.363×(BMI)+0.002×(尿酸)+0.166×(性别)。结论性别、BMI和尿酸是膝关节骨关节炎WOMAC评分的影响因素。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：尿酸, 膝关节骨关节炎, WOMAC骨关节炎指数

Abstract：Objective To assess the effect of serum uric acid to the WOMAC index in the osteoarthritis (OA) patients.Methods A total 312 patients were included in the study.Serum acid and other indexes were detected for Pearson correlation analysis and multivariable linear regression model.Results The data indicated the serum uric acid correlated with WOMAC negatively (r＝－0.824 8，P＜0.000 1).The linear regression was found between gender，BMI，uric acid and WOMAC.The model is WOMAC＝－7.811+0.363×(BMI)+0.002×(uric acid)+0.166×(gender).Conclusion gender，BMI and uric acid are associated with WOMAC.

Key words： uric acid knee osteoarthritis WOMAC

作者简介: 作者简介：杨志奎(1975－ )，男，副主任医师，延安大学咸阳医院骨科，712000。

引用本文:

杨志奎，代加楠，曹熙，李永刚，李鹏，高鑫，刘冲. 血尿酸对膝骨关节炎患者WOMAC指数变化的影响研究[J]. 实用骨科杂志, 2017, 23(1): 28-31.
Yang Zhikui，Dai Jianan，Cao Xi，et al. The Association between Serum Uric Acid and WOMAC in Knee Osteoarthritis Patients. sygkzz, 2017, 23(1): 28-31.

链接本文:

http://www.sygkzz.com/CN/ 或 http://www.sygkzz.com/CN/Y2017/V23/I1/28

［1］Neogi T，Zhang Y.Epidemiology of osteoarthritis［J］.Rheum Dis Clin North Am，2013，39(1)：1-19.
［2］Nowatzky J，Howard R，Pillinger MH，et al.The role of uric acid and other crystals in osteoarthritis［J］.Curr Rheumatol Rep，2010，12(2)：142-148.
［3］Leung YY，Thumboo J，Wong BS，et al.Colchicine effectiveness in symptom and inflammation modification in knee osteoarthritis (colkoa)：Study protocol for a randomized controlled trial［J］.Trials，2015(16)：200.
［4］中华医学会风湿病学分会.骨关节炎诊断及治疗指南［J］.中华风湿病学杂志，2010，14(6)：416.
［5］Wang L，Lee M，Zhang Z，et al.Does preoperative rehabilitation for patients planning to undergo joint replacement surgery improve outcomes? A systematic review and meta-analysis of randomised controlled trials［J］.BMJ Open，2016，6(2)：e009857.
［6］Bellamy N，Kirwan J，Boers M，et al.Recommendations for a core set of outcome measures for future phase iii clinical trials in knee，hip，and hand osteoarthritis.
Consensus development at omeract iii［J］.J Rheumatol，1997，24(4)：799-802.
［7］Bellamy N，Buchanan WW，Goldsmith CH，et al.Validation study of womac：A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee［J］.J Rheumatol，1988，15(12)：1833-1840.
［8］Escobar A，Riddle DL.Concordance between important change and acceptable symptom state following knee arthroplasty：The role of baseline scores［J］.Osteoarthritis Cartilage，2014，22(8)：1107-1110.
［9］Sellam J，Berenbaum F.Is osteoarthritis a metabolic disease?［J］.Joint Bone Spine，2013，80(6)：568-573.
［10］Zhuo Q，Yang W，Chen J，et al.Metabolic syndrome meets osteoarthritis［J］.Nat Rev Rheumatol，2012，8(12)：729-737.
［11］Sun Y，Brenner H，Sauerland S，et al.Serum uric acid and patterns of radiographic osteoarthritis-the ulm osteoarthritis study［J］.Scand J Rheumatol，2000，29(6)：380-386.
［12］Billiet L，Doaty S，Katz JD，et al.Review of hyperuricemia as new marker for metabolic syndrome［J］.ISRN Rheumatol，2014，2014：852954.
［13］Ding X，Zeng C，Wei J，et al.The associations of serum uric acid level and hyperuricemia with knee osteoarthritis［J］.Rheumatol Int，2016，36(4)：567-573.
［14］Schouten JS，van den Ouweland FA，Valkenburg HA.A 12 year follow up study in the general population on prognostic factors of cartilage loss in osteoarthritis of the knee［J］.Ann Rheum Dis，1992，51(8)：932-937.
［15］Denoble AE，Huffman KM，Stabler TV，et al.Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation［J］.Proc Natl Acad Sci USA，2011，108(5)：2088-2093.
［16］Waldron JL，Ashby HL，Razavi C，et al.The effect of the systemic inflammatory response，as provoked by elective orthopaedic surgery，on serum uric acid in patients without gout：A prospective study［J］.Rheumatology (Oxford)，2013，52(4)：676-678.
［17］Schorn C，Janko C，Munoz L，et al.Sodium and potassium urate crystals differ in their inflammatory potential［J］.Autoimmunity，2009，42(4)：314-316.
［18］Stevens M，Paans N，Wagenmakers R，et al.The influence of overweight/obesity on patient-perceived physical functioning and health-related quality of life after primary total hip arthroplasty［J］.Obes Surg，2012，22(4)：523-529.
［19］Kessler S，Kafer W.Overweight and obesity：Two predictors for worse early outcome in total hip replacement?［J］.Obesity (Silver Spring)，2007，15(11)：2840-2845.
［20］Judge A，Batra RN，Thomas GE，et al.Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery：Prospective cohort study［J］.Osteoarthritis Cartilage，2014，22(3)：431-439.
［21］Jones CA，Voaklander DC，Johnston DW，et al.The effect of age on pain，function，and quality of life after total hip and knee arthroplasty［J］.Arch Intern Med，2001，161(3)：454-460.